MY ACCOUNT | NEWSLETTER |

Animal parasiticides market worth $14 billion


The animal parasiticides industry is expected to witness significant growth in the near future. In terms of revenue, the market was estimated to be worth $10.6 billion in 2022 and is poised to reach more than $14 billion by 2027, growing at a CAGR of 5.8% according to a new report by Markets and Markets.

This growth can be attributed to increasing awareness of pet health, increasing pet ownership, and the rising demand for pet health products. Increasing disposable incomes, the rising trend of pet humanization, and an increasing number of pet owners are some of the major factors driving the growth of the pet parasiticides market.

Growing awareness of pet health and increasing awareness of parasitic diseases in pets is also expected to drive the growth of the pet parasiticides market. Additionally, technological advancements in pet parasiticide products, such as spot-on sprays and shampoos, are expected to fuel market growth over the near future.

Factors such as the rising demand for animal-derived food products, increasing investments by private players, growing concerns about zoonotic diseases, regulations for preventing the spread of animal diseases, growing companion animal ownership rates, and rising animal health expenditure are driving the growth of animal parasiticides market.

However, a shift toward vegetarianism and restrictions on the use of parasiticides in food-producing animals are expected to restrain the growth of this market during the forecast period.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Equine Herpesvirus Myeloencephalopathy: A Survivor's Story

Like0
Dislike0

Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs

Like0
Dislike0

Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis

Like0
Dislike0

Factors influencing the incidence and prognosis of canine mammary tumours

Like0
Dislike0

The Miniature Swine as a Model in Experimental and Translational Medicine

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top